Alternatives to tamoxifen
1 same-class SPL records vs tamoxifen - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Nolvadex
About tamoxifen
Tamoxifen (Soltamox) is a medicine that can treat breast cancer. It can also lower the chance of getting breast cancer in some people.
Used for: This medicine is used to treat breast cancer that has spread in adults. It can also be used after surgery to help prevent breast cancer from returning in adults. Tamoxifen can also lower the risk of invasive breast cancer after breast surgery and radiation for ductal carcinoma in situ (DCIS). Finally, it can lower the chance of getting breast cancer in women who are at high risk.
1 Selective Estrogen Receptor Modulator (SERM) peers (wide set)
tamoxifen vs raloxifene · FAERS reaction fields
FAERS top-reaction field "Tiredness" shows the widest count spread between tamoxifen and raloxifene in this extract (391-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | tamoxifen | raloxifene |
|---|---|---|
| Tiredness | 391 | - |
| Feeling sick to your stomach | 337 | - |
| Loose stools | 274 | - |
| Joint pain | 271 | - |
| Cancer getting worse | 249 | - |
| Pain | 243 | 85 |
| Throwing up | 224 | - |
| Difficulty breathing | 221 | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
tamoxifen peer mix vs class inventory
Peer mix
0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Selective Estrogen Receptor Modulator (SERM): 2 drugs.
Frequently Asked Questions
What same-class SPL records sit beside tamoxifen? ▼
Reading a wide Selective Estrogen Receptor Modulator (SERM) peer set (1 records)
tamoxifen (Nolvadex) sits in a wide Selective Estrogen Receptor Modulator (SERM) peer set (1 of 1 class peers shown). Labeled indication field for tamoxifen: This medicine is used to treat breast cancer that has spread in adults.
Top FAERS reaction fields for tamoxifen total 2,638 reports across 10 reactions, set beside raloxifene. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for tamoxifen: see also the generic vs brand label guide when reading Nolvadex SPL strings.
Read our methodology - how this data is sourced, computed, and verified.